Cervical Myelopathy in Hip Fracture Patients.
Flynn Rowan
Primary Investigator
Brief description of study
What is the purpose of this study?
Recent evidence has demonstrated a high rate of undiagnosed cervical myelopathy in patients presenting with hip fractures from a ground level fall. Identification and treatment of cervical myelopathy can help prevent falls and future fragility fractures. The purpose of this study is to screen ground level fall hip fracture patients for cervical myelopathy using a history, physical exam, and then an MRI if indicated.
Detailed description of study
What will happen during the study?
With this study, we want to see if asking additional questions and doing a physical of patients who come into the hospital with hip fractures identifies cervical myelopathy that may otherwise be missed and help those patients get proper treatment.
The study team will do a physical exam and take a history from the patient for research purposes, looking for signs/symptoms of cervical myelopathy. If it is determined the patient likely has cervical myelopathy, as standard of care, the patient will be offered an MRI and possibly be referred to a surgeon.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Hip fracture, Cervical myelopathy
-
Age: 50 years - 100 years
-
Gender: All
Inclusion criteria:
- Admitted to Eskenazi or Methodist hospital for a hip fracture (femoral neck, intertrochanteric, subtrochanteric, or pertrochanteric fracture) that was caused by a ground level fall
Exclusion criteria:
- Neurologic or cognitive disorder explaining the fall (dementia, Parkinson's disease, delirium, etc.)
- Syncopal fall caused by stroke or a heart condition
